Novartis Shareholders Give Green Light To Sandoz Spinoff

Separation Of Standalone Generics And Biosimilars Firm Expected To Proceed On 4 October

Traffic light on green
Novartis shareholders have given the go-ahead to spin off Sandoz • Source: Shutterstock

More from Strategy

More from Business